[Immunogenic cardiac amyloidosis. Value of ultrasonography and endomyocardial biopsy].
The development of one dimensional, and more especially two dimensional, cardiac ultrasonography associated with a safe technique of percutaneous endomyocardial biopsy has radically changed the diagnostic approach to cardiac amyloidosis. Prior to the widespread use of these techniques, the ante-mortem diagnosis was only made in 25 p. cent of patients presenting this form of infiltrating cardiomyopathy. The description of a recent case serves as an introduction to a brief review of cardiac amyloidosis based essentially on the two new diagnostic techniques of cardiac ultrasonography and endomyocardial biopsy.